Experimental study of 131I-caerin 1.1 and 131I-c(RGD)2 for internal radiation therapy of esophageal cancer xenografts-Reference-Cited by-同舟云学术

Experimental study of 131I-caerin 1.1 and 131I-c(RGD)2 for internal radiation therapy of esophageal cancer xenografts

Published:2023-08 Issue: Volume:164 Page:114891
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

He Tiantian,Du Juan,Zhu Keke,Zhou Yixuan,Xiao Zewei,Liu Wenjie,Ren Weiwei,Liu Xiongying,Chen Tongsheng,Liu Wenjuan,Chen Zhuanming,Ni Guoying,Liu Xiaosong,Wang Tianfang^ORCID,Quan Jiangtao,Zhang Peipei,Yuan Jianwei

Funder

National Natural Science Foundation of China

Guangzhou Science and Technology Program Key Projects

Guangzhou Municipal Science and Technology Project

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference19 articles.

1. Expression of the Na+/I- symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus;Altorjay;BMC Cancer,2007

2. Thyroid Cancer Radiotheragnostics: the case for activity adjusted 131I therapy.;Avram;Clin. Transl. Imaging,2018

3. Caerin 1.1 and 1.9 peptides from Australian tree frog inhibit antibiotic-resistant bacteria growth in a murine skin infection model;Chen;Microbiol Spectr.,2021

4. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017;Fan;Cancer Med,2020

5. Recent advances in pretargeted radioimmunotherapy;Gruaz-Guyon;Curr. Med. Chem., Curr. Med. Chem.,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the efficacy of cancer immunotherapy by host-defence caerin 1.1 and 1.9 peptides;Human Vaccines & Immunotherapeutics;2024-08-28

2. Computational studies and synthesis of ¹³¹iodine-labeled nocardiotide A analogs as a peptide-based theragnostic radiopharmaceutical ligand for cancer targeting SSTR2;RSC Advances;2024